Clinical Trials Logo

Clinical Trial Summary

To evaluate the change of blood perfusion before/after the use of Endostar, discuss the time sequence of Endostar TM in treating advanced lung adenocarcinoma in normalization window period.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01564329
Study type Interventional
Source Simcere Pharmaceutical Co., Ltd
Contact You Lu, MD
Phone 86-028-85422114
Email radyoulu@hotmail.com
Status Recruiting
Phase Phase 2
Start date March 2012
Completion date July 2013